Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Junko Morii"'
Autor:
Yasuo Yanagi, Kanji Takahashi, Tomohiro Iida, Fumi Gomi, Hiroshi Onishi, Junko Morii, Taiji Sakamoto
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 10, Pp 2629-2644 (2024)
Abstract Introduction This study evaluated the cost-effectiveness of anti-vascular endothelial growth factor (VEGF) therapies for subtypes of neovascular age-related macular degeneration (nAMD) from the societal perspective, and for any nAMD from the
Externí odkaz:
https://doaj.org/article/d2dd1258d1754fc3827dbb4d69d7b1a6
Autor:
Masayoshi Shinjoh, Kanae Togo, Tomoyuki Hayamizu, Naohiro Yonemoto, Junko Morii, Johnna Perdrizet, Kazumasa Kamei
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 485-497 (2024)
Background The Japanese National Immunization Program currently includes the pediatric 13 valent pneumococcal conjugate vaccine (PCV13) to prevent pneumococcal infections. We aimed to evaluate the cost-effectiveness of 20-valent PCV (PCV20) as a pedi
Externí odkaz:
https://doaj.org/article/71b05513c01b4d099126da3986cf1959
Autor:
Yasuo Yanagi, Kanji Takahashi, Tomohiro Iida, Fumi Gomi, Junko Morii, Eriko Kunikane, Taiji Sakamoto
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 4, Pp 2005-2021 (2023)
Abstract Introduction Neovascular age-related macular degeneration (nAMD) is the world’s leading cause of blindness in elderly people. While anti-vascular endothelial growth factor (VEGF) treatments are used as the first option for patients with nA
Externí odkaz:
https://doaj.org/article/1c8ea6a198a141b39076c05cade60bd9
Autor:
Yasuo Yanagi, Kanji Takahashi, Tomohiro Iida, Fumi Gomi, Junko Morii, Eriko Kunikane, Taiji Sakamoto
Publikováno v:
Ophthalmology and Therapy, Vol 12, Iss 5, Pp 2821-2822 (2023)
Externí odkaz:
https://doaj.org/article/69898440c1b84610abdd8d9fb5086f10